Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time

Gut

Volumn 69, Issue 3, 2019, Pages 502-512

  de Groot, Pieter ^a   Scheithauer, Torsten ^a   Bakker, Guido J ^a   Prodan, Andrei ^a   Levin, Evgeni ^a   Khan, Muhammad Tanweer ^b   Herrema, Hilde ^a   Ackermans, Mariette ^a   Serlie, Mireille J M ^a   de Brauw, Maurits ^c   Levels, Johannes H M ^a   Sales, Amber ^a   Gerdes, Victor E ^a   Ståhlman, Marcus ^b   Schimmel, Alinda W M ^a   Dallinga Thie, Geesje ^a   Bergman, Jacques J G H M ^a   Holleman, Frits ^a   Hoekstra, Joost B L ^a   Groen, Albert ^a   Bäckhed, Fredrik ^b   Nieuwdorp, Max ^a   more..

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Department of Orthopaedic Surgery   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CCL2 PROTEIN, HUMAN; GLUCOSE; MONOCYTE CHEMOTACTIC PROTEIN 1; VOLATILE FATTY ACID;

ADULT; AGED; BLOOD; CHEMISTRY; DONOR; ENERGY METABOLISM; FECAL MICROBIOTA TRANSPLANTATION; FECES; GASTRIC BYPASS SURGERY; GASTROINTESTINAL TRANSIT; GENE EXPRESSION; GENETICS; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; LIPOLYSIS; MALE; METABOLIC SYNDROME X; METABOLISM; METABOLOMICS; MIDDLE AGED; PATHOPHYSIOLOGY; SUBCUTANEOUS FAT; YOUNG ADULT;

ADULT; AGED; BILE ACIDS AND SALTS; CHEMOKINE CCL2; ENERGY METABOLISM; FATTY ACIDS, VOLATILE; FECAL MICROBIOTA TRANSPLANTATION; FECES; GASTRIC BYPASS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRANSIT; GENE EXPRESSION; GLUCOSE; HUMANS; INSULIN RESISTANCE; LIPOLYSIS; MALE; METABOLIC SYNDROME; METABOLOMICS; MIDDLE AGED; SUBCUTANEOUS FAT; TISSUE DONORS; YOUNG ADULT;

EID: 85066834571     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2019-318320     Document Type: Article

References (42)

1. Cefalu WT, Bray GA, Home PD, et al. Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors’ Expert Forum. Diabetes Care 2015;38:1567–82.
2. Liou AP, Paziuk M, Luevano JM, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013;5:178ra41.
3. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027–31.
4. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009;457:480–4.
5. Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature 2006;444:1022–3.
6. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013;341:1241214.
7. Goodrich JK, Waters JL, Poole AC, et al. Human genetics shape the gut microbiome. Cell 2014;159:789–99.
8. Mushref MA, Srinivasan S. Effect of high fat-diet and obesity on gastrointestinal motility. Ann Transl Med 2013;1:14.
9. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013;498:99–103.
10. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012;143:913–6.
11. Kootte RS, Levin E, Salojärvi J, et al. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. Cell Metab 2017;26:611–9.
12. Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation. Cell Metab 2015;22:228–38.
13. Soeters MR, Lammers NM, Dubbelhuis PF, et al. Intermittent fasting does not affect whole-body glucose, lipid, or protein metabolism. Am J Clin Nutr 2009;90:1244–51.
14. De Baere S, Eeckhaut V, Steppe M, et al. Development of a HPLC-UV method for the quantitative determination of four short-chain fatty acids and lactic acid produced by intestinal bacteria during in vitro fermentation. J Pharm Biomed Anal 2013;80:107–15.
15. Metcalf AM, Phillips SF, Zinsmeister AR, et al. Simplified assessment of segmental colonic transit. Gastroenterology 1987;92:40–7.
16. Koh A, Molinaro A, Ståhlman M, et al. Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1. Cell 2018;175:947–61.
17. Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Ser B 2005;67:301–20.
18. Meinshausen N, Bühlmann P. Stability selection. J R Stat Soc Ser B 2010;72:417–73.
19. Reijnders D, Goossens GH, Hermes GD, et al. Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial. Cell Metab 2016;24:341.
20. Ge X, Zhao W, Ding C, et al. Potential role of fecal microbiota from patients with slow transit constipation in the regulation of gastrointestinal motility. Sci Rep 2017;7:441.
21. Ott B, Skurk T, Hastreiter L, et al. Effect of caloric restriction on gut permeability, inflammation markers, and fecal microbiota in obese women. Sci Rep 2017;7:11955.
22. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55–60.
23. Aydin Ö, Nieuwdorp M, Gerdes V. The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes. Curr Diab Rep 2018;18:55.
24. Caesar R, Tremaroli V, Kovatcheva-Datchary P, et al. Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling. Cell Metab 2015;22:658–68.
25. Sayin SI, Wahlström A, Felin J, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013;17:225–35.
26. Weingarden AR, Chen C, Bobr A, et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol 2014;306:G310–G319.
27. Sonne DP, van Nierop FS, Kulik W, et al. Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes. J Clin Endocrinol Metab 2016;101:3002–9.
28. Trabelsi MS, Daoudi M, Prawitt J, et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun 2015;6:7629.
29. Kuipers F, Bloks VW, Groen AK. Beyond intestinal soap-bile acids in metabolic control. Nat Rev Endocrinol 2014;10:488–98.
30. Bunnett NW. Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract. J Physiol 2014;592:2943–50.
31. Piccolo BD, Graham JL, Stanhope KL, et al. Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model. Am J Physiol Endocrinol Metab 2016;310:E958–E969.
32. Panten U, Langer J. Mechanism of 3-phenylpyruvate-induced insulin release from isolated pancreatic islets. Biochem J 1981;198:353–6.
33. Sanna S, van Zuydam NR, Mahajan A, et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet 2019;51:600–5.
34. Jie Z, Xia H, Zhong SL, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun 2017;8:845.
35. Meijnikman AS, Gerdes VE, Nieuwdorp M, et al. Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans. Endocr Rev 2018;39:133–53.
36. Tap J, Mondot S, Levenez F, et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009;11:2574–84.
37. Brahe LK, Le Chatelier E, Prifti E, et al. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr Diabetes 2015;5:e159.
38. Crusell MKW, Hansen TH, Nielsen T, et al. Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum. Microbiome 2018;6:89.
39. Bergman BC, Brozinick JT, Strauss A, et al. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. Am J Physiol Endocrinol Metab 2015;309:E398–E408.
40. Zeevi D, Korem T, Zmora N, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell 2015;163:1079–94.
41. Deschasaux M, Bouter KE, Prodan A, et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat Med 2018;24:1526–31.
42. Marques RE, Marques PE, Guabiraba R, et al. Exploring the Homeostatic and Sensory Roles of the Immune System. Front Immunol 2016;7.